The experimental drug, which has been touted as the next miracle for reducing cholesterol levels has been stated to be safe, after initial trials. The result means that the medicine is a step closer to being approved and reaching the market.

The results of the tests will be showcased on Wednesday, during the annual conference of the American Heart Association. According to the findings of the report, apart from being safe for consumption, the drug, anacetrapib was found to have reduced bad cholesterol levels, while simultaneously reducing bad cholesterol levels.

Lead Author Dr. Christopher Cannon stated that the tests had shown some very reassuring results. The complete detail regarding the trial has been published in the November 18 issue of the publication, New England Journal of Medicine.

Though, a Cardiologist from Boston working with the Brigham and Women’s Hospital, Dr. Cannon informed that it would take another 4-5 years to release the drug, as trials were still in their nascent stage. He added that it would take quite a few years for the drug to be released in market.

Researchers and doctors from world over have expressed interest regarding the findings of the study and it seems that everyone would be excited to know about the outcomes of further trials on anacetrapib.